MIRA PHARMACEUTICALS INC (MIRA) Stock Analyst Ratings
USA - NASDAQ:MIRA - US60458C1045 - Common Stock
1.44 USD
-0.09 (-5.88%)
1.52 USD
+0.08 (+5.56%)
ChartMill assigns a Buy % Consensus number of 83% to MIRA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.06. This target is 112.5% above the current price.
MIRA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MIRA.
In the previous month the buy percentage consensus was at a similar level.
MIRA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-30 | Rodman & Renshaw | Initiate | Buy |
| 2024-08-05 | Ascendiant Capital | Initiate | Buy |
MIRA PHARMACEUTICALS INC / MIRA FAQ
What is the average price target for MIRA PHARMACEUTICALS INC (MIRA) stock?
7 analysts have analysed MIRA and the average price target is 3.06 USD. This implies a price increase of 112.5% is expected in the next year compared to the current price of 1.44.
Can you provide the consensus rating for MIRA PHARMACEUTICALS INC stock?
The consensus rating for MIRA PHARMACEUTICALS INC (MIRA) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.